The Alzheimer’s Disease Sequencing Project (ADSP) undertook whole exome sequencing
in 5,740 late-onset Alzheimer disease (AD) cases and 5,096 cognitively normal controls …

We performed whole-exome and whole-genome sequencing in 927 late-onset Alzheimer
disease (LOAD) cases, 852 early-onset AD (EOAD) cases, and 1273 controls from France. We …

The SORL1 protein plays a protective role against the secretion of the amyloid β peptide, a
key event in the pathogeny of Alzheimer’s disease. We assessed the impact of SORL1 rare …

Causative variants in APP, PSEN1 or PSEN2 account for a majority of cases of autosomal
dominant early-onset Alzheimer disease (ADEOAD, onset before 65 years). Variant detection …

Via whole-exome sequencing, we identified rare autosomal-recessive variants in UBA5 in
five children from four unrelated families affected with a similar pattern of severe intellectual …

Alzheimer’s disease (AD), the leading cause of dementia, has an estimated heritability of
approximately 70% 1 . The genetic component of AD has been mainly assessed using genome-…

Introduction A minority of patients with sporadic early‐onset Alzheimer's disease (AD) exhibit
de novo germ line mutations in the autosomal dominant genes such as APPPSEN1, or …

To assess the role of rare copy number variations in Alzheimer's disease (AD), we conducted
a case–control study using whole-exome sequencing data from 522 early-onset cases and …

Objective: To study the association between ABCA7 rare coding variants and Alzheimer
disease (AD) in a case-control setting. Methods: We conducted a whole exome analysis among …

Modeling splicing is essential for tackling the challenge of variant interpretation as each
nucleotide variation can be pathogenic by affecting pre‐mRNA splicing via disruption/creation of …